SUNNYVALE, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (Nasdaq: MDCC - News), a leader in innovative solutions for drug discovery and life sciences research, today introduced FlexStation® 3 next- generation multi-detection benchtop reader with fluidics. FlexStation 3 is based on Molecular Devices’ popular SpectraMax® M5 multi-detection system with the addition of liquid handling. The system was developed for use in research, assay development and lead optimization environments to address applications for researchers performing assay development and small-scale screens. FlexStation 3 will debut today at the Annual Meeting of the Society for Biomolecular Sciences (SBS) in Seattle, Washington, in Molecular Devices Booth #2501.
